App surpasses the ‘gold standard’ of sensitivity, Baylor University researchers say
A Baylor University researcher’s prototype smartphone app — designed to help parents detect early signs of various eye diseases in their children such as retinoblastoma, an aggressive pediatric eye cancer — has passed its first big test.
The CRADLE app (ComputeR Assisted Detector LEukocoia) searches for traces of abnormal reflections from the retina called leukocoria or “white eye,” a primary symptom of retinoblastoma, as well as other common eye disorders. The study, published in the journal Science Advances, found the app is an effective tool to augment clinical leukocoria screenings, allowing parents to efficiently and effectively screen their children more often throughout their development.
CRADLE — developed by Baylor University researchers Bryan F. Shaw, Ph.D., associate professor of chemistry and biochemistry, along with Greg Hamerly, Ph.D., associate professor of computer science — searches through family photographs for signs of leukocoria.
According to the study’s first author, Baylor senior University Scholar Micheal Munson, researchers determined the sensitivity, specificity and accuracy of the prototype by analyzing more than 50,000 photographs of children taken prior to their diagnosis. For children with diagnosed eye disorders, CRADLE was able to detect leukocoria for 80 percent of the children. The app detected leukocoria in photos that were taken on average of 1.3 years prior to their official diagnosis.
The effectiveness of traditional screenings during a general physical exam is limited, with signs of retinoblastoma via the detection of leukocoria in only 8 percent of cases. CRADLE’s sensitivity for children age 2 and younger surpassed 80 percent. That 80 percent threshold is regarded by ophthalmologists as the ‘‘gold standard” of sensitivity for similar devices, Munson said.
Researchers found the CRADLE app to be more effective simply by the breadth and frequency of its sample sizes: everyday family photos, according to the study. Given the number of photos taken by family and friends and the variety of environments, there is a variety of opportunities for light to reflect off the ocular lesions regardless of its location in the eye.
As the app’s algorithm has become more sophisticated, its ability to detect even slight instances of leukocoria has improved.
“This is one of the most critical parts of building the app,” Shaw said. “We wanted to be able to detect all hues and intensities of leukocoria. As a parent of a child with retinoblastoma, I am especially interested in detecting the traces of leukocoria that appear as a ‘gray’ pupil and are difficult to detect with the naked eye.”
Initially, the CRADLE app was used primarily to identify retinoblastoma — a rare eye disease that is the most common form of eye cancer in children up to age 5. Shaw’s own experience as a parent of a child with retinoblastoma formed the genesis of the app.
Shaw and Hamerly created the app in 2014 for the iPhone and in 2015 for Android devices after Shaw’s son, Noah, lost his right eye, but his left eye was able to be salvaged. He is now 11.
“We suspected that the app would detect leukocoria associated with other more common disorders and some rare ones,” Shaw said. “We were right. So far parents, and some doctors, have used it to detect cataract, myelin retinal nerve fiber layer, refractive error, Coats’ disease, and of course retinoblastoma.”
Lead author Munson is a prime example of Baylor’s focus on meaningful undergraduate research experiences that take place alongside Baylor faculty. In the spring, he received the Goldwater Scholarship from the Barry M. Goldwater Scholarship and Excellence in Education Program, one of the top undergraduate scholarships given in the natural sciences, engineering and mathematics Munson is concentrating his studies in biochemistry and applied mathematics, and along with conducting research with Shaw, has spent three summers at Johns Hopkins School of Medicine, where he studied type II pulmonary arterial hypertension.
“Mike (Munson) just knocked on my door and asked for a job,” Shaw said. “After he had worked about six months on the project, I handed him the reins.
“Baylor really is in the Goldilocks zone of undergraduate research,” Shaw said. “We are not too big that they fall through the cracks and we’re not too small that they don’t have good projects to work on.”
“I just kept the goal in mind: saving the sight and potentially the lives of children throughout the world,” Munson said.
Shaw said they are retraining the algorithm with Baylor undergraduates currently tagging and sorting about 100,000 additional photos. He said they also are looking at additional features to cut down on false positive detections.
The app can be downloaded for free and can be found under the name “White Eye Detector.”
The Latest on: ComputeR Assisted Detector LEukocoia
via Google News
The Latest on: ComputeR Assisted Detector LEukocoia
- Diagnos announces a 3-year partnership with the University of Montreal Hospital Centre on the use of Artificial Intelligenceon January 19, 2021 at 12:25 pm
BROSSARD – Diagnos Inc. (TSXV: ADK) (OTCQB: DGNOF), a leader in early detection of critical health problems through the use of artificial intelligence, reported a three-year framework partnership ...
- DIAGNOS announces a 3-year partnership agreement with the University of Montreal Hospital Centre (CHUM) on the use of Artificial Intelligenceon January 19, 2021 at 6:55 am
BROSSARD, Quebec, (GLOBE NEWSWIRE) -- Diagnos Inc. ('DIAGNOS' or 'Company') (TSX Venture Exchange: ADK) (OTCQB: DGNOF), a leader ...
- Artificial Intelligence (AI) in Healthcare Market Size Worth $61.59 Billion By 2027 | CAGR of 43.6% By Reports and Dataon January 19, 2021 at 12:24 am
Adoption of advanced technologies by pharmaceutical companies and hospitals is driving the demand for artificial intelligence ...
- DIAGNOS Announces Partnership in Saudi Arabia with Magrabi Hospitals and Centers to Screen Diabetic Patientson January 15, 2021 at 9:07 pm
About DIAGNOS DIAGNOS is a public Canadian company dedicated to early detection of health problems ... its applications such as CARA (Computer Assisted Retina Analysis). CARA's artificial ...
- Kaseya Ends 2020 Empowering Customers with Best-in-Class Product Innovations to Thrive in a Post-COVID Worldon January 13, 2021 at 10:01 pm
Kaseya®, the leading provider of IT and security management solutions for managed service providers (MSPs) and small to medium-sized businesses (SMBs), announced today that the company grew by over 20 ...
- Becky Lyne’s five tips to improve your running techniqueon January 13, 2021 at 7:42 am
As an 800m runner Becky Lyne ran 1:58.20 and after winning bronze at the European Championships in 2006 behind two Russians she was named British Athletics Writers’ Association female athlete of the ...
- 2021 Lexus LC 500 Inspiration Series: Performance Luxury Takes Flighton January 12, 2021 at 2:49 pm
The partnership ultimately assisted Muroya on his path to winning ... Pre-Collision System with Pedestrian Detection is standard and includes features such as Frontal Collision Warning (FCW ...
- OPINION: Tasmanian needs to fundamentally rethink our approach to road safetyon January 8, 2021 at 7:33 pm
We simply can't continue to implement the same strategies and the same way of thinking that has underpinned the strategy over the past 10 years ...
- Reolink Adds Three More AI-Infused 5MP & 4K Ultra HD Security Cameras to Its Smart Detection Lineupon January 5, 2021 at 11:03 pm
Last but not least, we don't think AI-assisted surveillance has to be expensive ... PoE dome cameras newly added to the Reolink smart detection series. RLC-820A - Outdoor/indoor 4K/2160p ...
- DIAGNOS Provides Market Activity Update TSX Venture Exchange:ADKon January 5, 2021 at 11:31 am
Diagnos Inc. ('DIAGNOS' or the 'Corporation') (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial ...
via Bing News